Physician

Joseph Anthony Veys, MD

According to 2025 Medicare claims, Joseph Veys, MD (NPI: 1861464208) practices urology in the Dalton, GA market, with the plurality of this provider's patient population coming from Whitfield, GA. This provider's primary affiliated billing organization is NORTH GEORGIA UROLOGY CENTER, PC, INC (NPI: 1861413197; TIN: 58-2650795) and primary practice location at 30720-3009. Veys is affiliated with the AdvantagePoint Health Alliance - Western North Carolina, LLC (ACO ID: A5039) and MID-TENNESSEE COMMUNITY ACO LLC (ACO ID: A5543), participating under the MSSP model.

Veys' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 598 traditional Medicare patients, billed 19,109 HCPCS/CPT codes, and received $418,992 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,261 prescription claims across 349 beneficiaries totaling $1,963,176 in drug costs, led by Xtandi (Enzalutamide). DME data shows 58 claims. Open Payments data shows 61 records totaling $1,808. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $579,204 and ending at $418,992. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $123,177 to $1,963,176. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $534 and ending at $464.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	724	28,108	$579,204
2016	891	30,340	$570,469
2017	1,026	35,858	$1,115,237
2018	819	43,928	$788,436
2019	761	52,929	$609,133
2020	746	41,513	$502,858
2021	699	37,385	$415,402
2022	778	35,045	$505,011
2023	681	28,745	$890,736
2024	598	19,109	$418,992

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	318	1,331	$123,177
2016	320	1,466	$365,069
2017	327	1,281	$282,880
2018	330	1,339	$435,725
2019	332	1,178	$855,963
2020	308	1,087	$895,834
2021	315	1,040	$1,406,524
2022	332	1,022	$1,693,958
2023	393	1,287	$2,366,531
2024	349	1,261	$1,963,176

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	80	$23,799
2016	N/R	64	$23,302
2017	N/R	88	$35,069
2018	N/R	76	$42,151
2019	N/R	20	$12,977
2020	N/R	62	$42,607
2021	N/R	59	$53,055
2022	N/R	40	$51,428
2023	N/R	68	$40,025
2024	N/R	58	$42,981

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	145	206	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	340	542	$58
36415	Insertion of needle into vein for collection of blood sample	180	281	$9
51798	Ultrasound measurement of bladder capacity after voiding	226	338	$7
81000	Manual urinalysis test with examination using microscope, non-automated	371	666	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	101	3,030	$1,404,539
Nubeqa	Darolutamide	20	600	$265,230
Orgovyx	Relugolix	53	1,590	$134,641
Gemtesa	Vibegron	122	4,890	$79,116
Myrbetriq	Mirabegron	53	2,455	$36,601

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	17	$33,137
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	23	$9,400
A4332	Lubricant, individual sterile packet, each	N	N/R	18	$444

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	61	$1,808	Ferring Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph Anthony Veys, MD?

Tedicare shows public-source Medicare data for Joseph Anthony Veys, MD (NPI 1861464208), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Anthony Veys, MD have ACO affiliation data?

Joseph Anthony Veys, MD is shown with ACO affiliation data for AdvantagePoint Health Alliance - Western North Carolina, LLC (MSSP, ACO ID A5039) and MID-TENNESSEE COMMUNITY ACO LLC (MSSP, ACO ID A5543).

What billing organization is linked to Joseph Anthony Veys, MD?

Joseph Anthony Veys, MD is linked to NORTH GEORGIA UROLOGY CENTER, PC, INC (billing NPI 1861413197) in the available physician profile data.

Does Joseph Anthony Veys, MD have Open Payments data?

Joseph Anthony Veys, MD has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.